Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asger Lund

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Diabetes|March 16, 2021
Glucagonostatic Potency of GLP-1 in Patients With Type 2 Diabetes, Patients With Type 1 Diabetes, and Healthy Control SubjectsJonatan I Bagger, Magnus F G Grøndahl, Asger Lund, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2017
Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and GlycemiaMikkel B Christensen, Asger Lund, Salvatore Calanna, et al.
International Journal of Molecular Sciences|August 25, 2019
The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A ReviewDavid S Mathiesen, Jonatan I Bagger, Natasha C Bergmann, et al.
Diabetes|October 2, 2020
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 InhibitionSofie Hædersdal, Asger Lund, Elisabeth Nielsen-Hannerup, et al.
European Journal of Endocrinology|August 17, 2022
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetesSofie Hædersdal, Asger Lund, Elisabeth Nielsen-Hannerup, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2021
Response to Letter to the Editor from McKee and McGill: "Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring"Caroline T B Juel, Thomas F Dejgaard, Carsten P Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2016
Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose InfusionAsger Lund, Jonatan I Bagger, Mikkel Christensen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2020
Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose MonitoringCaroline T B Juel, Thomas F Dejgaard, Carsten P Hansen, et al.
European Journal of Endocrinology|August 9, 2021
MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatinMads R Andersen, Malte P Suppli, Jonatan I Bagger, et al.
Diabetes Care|April 1, 2018
Effects of Smoking Versus Nonsmoking on Postprandial Glucose Metabolism in Heavy Smokers Compared With NonsmokersMagnus F Grøndahl, Jonatan I Bagger, Asger Lund, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Diabetes|March 16, 2021
Glucagonostatic Potency of GLP-1 in Patients With Type 2 Diabetes, Patients With Type 1 Diabetes, and Healthy Control SubjectsJonatan I Bagger, Magnus F G Grøndahl, Asger Lund, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2017
Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and GlycemiaMikkel B Christensen, Asger Lund, Salvatore Calanna, et al.
International Journal of Molecular Sciences|August 25, 2019
The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A ReviewDavid S Mathiesen, Jonatan I Bagger, Natasha C Bergmann, et al.
Diabetes|October 2, 2020
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 InhibitionSofie Hædersdal, Asger Lund, Elisabeth Nielsen-Hannerup, et al.
European Journal of Endocrinology|August 17, 2022
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetesSofie Hædersdal, Asger Lund, Elisabeth Nielsen-Hannerup, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2021
Response to Letter to the Editor from McKee and McGill: "Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring"Caroline T B Juel, Thomas F Dejgaard, Carsten P Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2016
Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose InfusionAsger Lund, Jonatan I Bagger, Mikkel Christensen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2020
Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose MonitoringCaroline T B Juel, Thomas F Dejgaard, Carsten P Hansen, et al.
European Journal of Endocrinology|August 9, 2021
MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatinMads R Andersen, Malte P Suppli, Jonatan I Bagger, et al.
Diabetes Care|April 1, 2018
Effects of Smoking Versus Nonsmoking on Postprandial Glucose Metabolism in Heavy Smokers Compared With NonsmokersMagnus F Grøndahl, Jonatan I Bagger, Asger Lund, et al.
Pageof 6